Mesenchymal Stem Cell Transplantation Increases Antioxidant Protein Expression and Ameliorates GP91/ROS/Inflammasome Signals in Diabetic Cardiomyopathy

Background: Cardiomyopathy is one of the complications associated with diabetes. Due to its high prevalence, diabetic cardiomyopathy has become an urgent issue for diabetic patients. Various pathological signals are related to diabetic cardiomyopathy progress, including inflammasome. Mesenchymal ste...

Full description

Bibliographic Details
Main Authors: Wei-Syun Hu, Tung-Sheng Chen, Ka-Hung Cheang, Wei-Yu Liao, Chin-Hsien Chang
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/9/11/381
_version_ 1797467774680825856
author Wei-Syun Hu
Tung-Sheng Chen
Ka-Hung Cheang
Wei-Yu Liao
Chin-Hsien Chang
author_facet Wei-Syun Hu
Tung-Sheng Chen
Ka-Hung Cheang
Wei-Yu Liao
Chin-Hsien Chang
author_sort Wei-Syun Hu
collection DOAJ
description Background: Cardiomyopathy is one of the complications associated with diabetes. Due to its high prevalence, diabetic cardiomyopathy has become an urgent issue for diabetic patients. Various pathological signals are related to diabetic cardiomyopathy progress, including inflammasome. Mesenchymal stem cell transplantation is full of potential for the treatment of diabetic cardiomyopathy because of stem cell cardiac regenerative capability. This study investigates whether mesenchymal stem cell transplantation shows therapeutic effects on diabetic cardiomyopathy through inflammasome signaling regulation. Methods: Wistar male rats were divided into three groups including Sham, T1DM (rats with type 1 diabetes) and T1DM + WJSC (T1DM rats receiving 1 × 10<sup>6</sup> stem cells per rat). Results: Compared to the Sham, experimental results indicated that several pathological conditions can be observed in heart tissues with T1DM, including structural change, fibrosis, oxidative stress elevation and inflammasome related protein expression. All of these pathological conditions were significantly improved in T1DM rats receiving mesenchymal stem cell transplantation (T1DM + WJSC). Furthermore, the experimental findings suggest that mesenchymal stem cell transplantation exerted antioxidant protein expression in diabetic heart tissues, resulting in a decrease in oxidative stress and inflammasome signaling blockage. Conclusion: These findings imply that mesenchymal stem cell transplantation shows therapeutic effects on diabetic cardiomyopathy through inflammasome regulation induced by oxidative stress.
first_indexed 2024-03-09T18:58:30Z
format Article
id doaj.art-42c3b48fa26d4eca88f555b16e68c626
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-09T18:58:30Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-42c3b48fa26d4eca88f555b16e68c6262023-11-24T05:14:12ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252022-11-0191138110.3390/jcdd9110381Mesenchymal Stem Cell Transplantation Increases Antioxidant Protein Expression and Ameliorates GP91/ROS/Inflammasome Signals in Diabetic CardiomyopathyWei-Syun Hu0Tung-Sheng Chen1Ka-Hung Cheang2Wei-Yu Liao3Chin-Hsien Chang4School of Medicine, College of Medicine, China Medical University, Taichung 40042, TaiwanGraduate Program of Biotechnology and Pharmaceutical Industries, National Taiwan Normal University, Taipei 11677, TaiwanGraduate Program of Biotechnology and Pharmaceutical Industries, National Taiwan Normal University, Taipei 11677, TaiwanTraditional Chinese Medicine Department, En Chu Kong Hospital, New Taipei City 40237, TaiwanTraditional Chinese Medicine Department, En Chu Kong Hospital, New Taipei City 40237, TaiwanBackground: Cardiomyopathy is one of the complications associated with diabetes. Due to its high prevalence, diabetic cardiomyopathy has become an urgent issue for diabetic patients. Various pathological signals are related to diabetic cardiomyopathy progress, including inflammasome. Mesenchymal stem cell transplantation is full of potential for the treatment of diabetic cardiomyopathy because of stem cell cardiac regenerative capability. This study investigates whether mesenchymal stem cell transplantation shows therapeutic effects on diabetic cardiomyopathy through inflammasome signaling regulation. Methods: Wistar male rats were divided into three groups including Sham, T1DM (rats with type 1 diabetes) and T1DM + WJSC (T1DM rats receiving 1 × 10<sup>6</sup> stem cells per rat). Results: Compared to the Sham, experimental results indicated that several pathological conditions can be observed in heart tissues with T1DM, including structural change, fibrosis, oxidative stress elevation and inflammasome related protein expression. All of these pathological conditions were significantly improved in T1DM rats receiving mesenchymal stem cell transplantation (T1DM + WJSC). Furthermore, the experimental findings suggest that mesenchymal stem cell transplantation exerted antioxidant protein expression in diabetic heart tissues, resulting in a decrease in oxidative stress and inflammasome signaling blockage. Conclusion: These findings imply that mesenchymal stem cell transplantation shows therapeutic effects on diabetic cardiomyopathy through inflammasome regulation induced by oxidative stress.https://www.mdpi.com/2308-3425/9/11/381cardiomyopathydiabetesinflammasomemesenchymal stem cellsreactive oxygen species
spellingShingle Wei-Syun Hu
Tung-Sheng Chen
Ka-Hung Cheang
Wei-Yu Liao
Chin-Hsien Chang
Mesenchymal Stem Cell Transplantation Increases Antioxidant Protein Expression and Ameliorates GP91/ROS/Inflammasome Signals in Diabetic Cardiomyopathy
Journal of Cardiovascular Development and Disease
cardiomyopathy
diabetes
inflammasome
mesenchymal stem cells
reactive oxygen species
title Mesenchymal Stem Cell Transplantation Increases Antioxidant Protein Expression and Ameliorates GP91/ROS/Inflammasome Signals in Diabetic Cardiomyopathy
title_full Mesenchymal Stem Cell Transplantation Increases Antioxidant Protein Expression and Ameliorates GP91/ROS/Inflammasome Signals in Diabetic Cardiomyopathy
title_fullStr Mesenchymal Stem Cell Transplantation Increases Antioxidant Protein Expression and Ameliorates GP91/ROS/Inflammasome Signals in Diabetic Cardiomyopathy
title_full_unstemmed Mesenchymal Stem Cell Transplantation Increases Antioxidant Protein Expression and Ameliorates GP91/ROS/Inflammasome Signals in Diabetic Cardiomyopathy
title_short Mesenchymal Stem Cell Transplantation Increases Antioxidant Protein Expression and Ameliorates GP91/ROS/Inflammasome Signals in Diabetic Cardiomyopathy
title_sort mesenchymal stem cell transplantation increases antioxidant protein expression and ameliorates gp91 ros inflammasome signals in diabetic cardiomyopathy
topic cardiomyopathy
diabetes
inflammasome
mesenchymal stem cells
reactive oxygen species
url https://www.mdpi.com/2308-3425/9/11/381
work_keys_str_mv AT weisyunhu mesenchymalstemcelltransplantationincreasesantioxidantproteinexpressionandamelioratesgp91rosinflammasomesignalsindiabeticcardiomyopathy
AT tungshengchen mesenchymalstemcelltransplantationincreasesantioxidantproteinexpressionandamelioratesgp91rosinflammasomesignalsindiabeticcardiomyopathy
AT kahungcheang mesenchymalstemcelltransplantationincreasesantioxidantproteinexpressionandamelioratesgp91rosinflammasomesignalsindiabeticcardiomyopathy
AT weiyuliao mesenchymalstemcelltransplantationincreasesantioxidantproteinexpressionandamelioratesgp91rosinflammasomesignalsindiabeticcardiomyopathy
AT chinhsienchang mesenchymalstemcelltransplantationincreasesantioxidantproteinexpressionandamelioratesgp91rosinflammasomesignalsindiabeticcardiomyopathy